1.
Kardiol Pol
; 81(2): 207-214, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36866400
RESUMO
The diagnosis of metabolic associated fatty liver disease (MAFLD) is significant for patients' prognosis, as the disease accelerates the development of cardiovascular complications and, on the other hand, cardiometabolic conditions are risk factors for the development of fatty liver diseases. This expert opinion presents principles of MAFLD diagnosis and standards of management to reduce cardiovascular risks in patients with MAFLD.